Fingerprint
Dive into the research topics of 'Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: Interim results from a multicenter phase I/II trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically